Related references
Note: Only part of the references are listed.Downregulated Kynurenine 3-Monooxygenase Gene Expression and Enzyme Activity in Schizophrenia and Genetic Association With Schizophrenia Endophenotypes
Ikwunga Wonodi et al.
ARCHIVES OF GENERAL PSYCHIATRY (2011)
Fluctuations in Endogenous Kynurenic Acid Control Hippocampal Glutamate and Memory
Ana Pocivavsek et al.
NEUROPSYCHOPHARMACOLOGY (2011)
Blockade of NMDA GluN2B receptors selectively impairs behavioral flexibility but not initial discrimination learning
Gemma L. Dalton et al.
PSYCHOPHARMACOLOGY (2011)
Galantamine augmentation of long-acting injectable risperidone for cognitive impairments in chronic schizophrenia
Jean-Pierre Lindenmayer et al.
SCHIZOPHRENIA RESEARCH (2011)
Alterations in Metabotropic Glutamate Receptor 1α and Regulator of G Protein Signaling 4 in the Prefrontal Cortex in Schizophrenia
David W. Volk et al.
AMERICAN JOURNAL OF PSYCHIATRY (2010)
Functional and Dysfunctional Synaptic Plasticity in Prefrontal Cortex: Roles in Psychiatric Disorders
Yukiori Goto et al.
BIOLOGICAL PSYCHIATRY (2010)
Learning and cognitive flexibility: frontostriatal function and monoaminergic modulation
Angie A. Kehagia et al.
CURRENT OPINION IN NEUROBIOLOGY (2010)
Activation of type 5 metabotropic glutamate receptors attenuates deficits in cognitive flexibility induced by NMDA receptor blockade
Mark R. Stefani et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
The Astrocyte-Derived alpha 7 Nicotinic Receptor Antagonist Kynurenic Acid Controls Extracellular Glutamate Levels in the Prefrontal Cortex
Hui-Qiu Wu et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2010)
More Is Less: A Disinhibited Prefrontal Cortex Impairs Cognitive Flexibility
Aaron J. Gruber et al.
JOURNAL OF NEUROSCIENCE (2010)
Differential Contributions of the Primate Ventrolateral Prefrontal and Orbitofrontal Cortex to Serial Reversal Learning
Rafal Rygula et al.
JOURNAL OF NEUROSCIENCE (2010)
CORTICAL KYNURENIC ACID BI-DIRECTIONALLY MODULATES PREFRONTAL GLUTAMATE LEVELS AS ASSESSED BY MICRODIALYSIS AND RAPID ELECTROCHEMISTRY
A. Konradsson-Geuken et al.
NEUROSCIENCE (2010)
Assessing cognitive function in clinical trials of schizophrenia
Jennifer H. Barnett et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2010)
Cortical Kynurenine Pathway Metabolism: A Novel Target for Cognitive Enhancement in Schizophrenia
Ikwunga Wonodi et al.
SCHIZOPHRENIA BULLETIN (2010)
Alterations of Cortical GABA Neurons and Network Oscillations in Schizophrenia
Guillermo Gonzalez-Burgos et al.
CURRENT PSYCHIATRY REPORTS (2010)
The Neuropsychopharmacology of Fronto-Executive Function: Monoaminergic Modulation
T.W. Robbins et al.
Annual Review of Neuroscience (2009)
L-kynurenine treatment alters contextual fear conditioning and context discrimination but not cue-specific fear conditioning
Amy C. Chess et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Neural circuits subserving behavioral flexibility and their relevance to schizophrenia
Stan B. Floresco et al.
BEHAVIOURAL BRAIN RESEARCH (2009)
Astrocyte-derived kynurenic acid modulates basal and evoked cortical acetylcholine release
A. Zmarowski et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2009)
Chronic infusion of PCP via osmotic mini-pumps: A new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance
Christian Spang Pedersen et al.
JOURNAL OF NEUROSCIENCE METHODS (2009)
Decreased cortical muscarinic receptors define a subgroup of subjects with schizophrenia
E. Scarr et al.
MOLECULAR PSYCHIATRY (2009)
Ventral Striatal Dopamine Modulation of Different Forms of Behavioral Flexibility
Desirae M. Haluk et al.
NEUROPSYCHOPHARMACOLOGY (2009)
CNTRICS Final Task Selection: Control of Attention
Keith H. Nuechterlein et al.
SCHIZOPHRENIA BULLETIN (2009)
Second-by-Second Analysis of Alpha 7 Nicotine Receptor Regulation of Glutamate Release in the Prefrontal Cortex of Awake Rats
Asa Konradsson-Geuken et al.
SYNAPSE (2009)
Galantamine for the treatment of cognitive impairments in people with schizophrenia
Robert W. Buchanan et al.
AMERICAN JOURNAL OF PSYCHIATRY (2008)
Cholinergic mediation of attention - Contributions of phasic and tonic increases in prefrontal cholinergic activity
Vinay Parikh et al.
MOLECULAR AND BIOPHYSICAL MECHANISMS OF AROUSAL, ALERTNESS, AND ATTENTION (2008)
Lesions of the basal forebrain impair reversal learning but not shifting of attentional set in rats
David Scott Tait et al.
BEHAVIOURAL BRAIN RESEARCH (2008)
Interaction of N-methyl-D-aspartate and group 5 metabotropic glutamate receptors on behavioral flexibility using a novel operant set-shift paradigm
Justin M. Darrah et al.
BEHAVIOURAL PHARMACOLOGY (2008)
N-Methyl-D-Aspartate Receptor and Calbindin-Containing Neurons in the Anterior Cingulate Cortex in Schizophrenia and Bipolar Disorder
Tsung-Ung W. Woo et al.
BIOLOGICAL PSYCHIATRY (2008)
Executive functioning component mechanisms and schizophrenia
John G. Kerns et al.
BIOLOGICAL PSYCHIATRY (2008)
Differential effects of inactivation of the orbitofrontal cortex on strategy set-shifting and reversal learning
Sarvin Ghods-Sharifi et al.
NEUROBIOLOGY OF LEARNING AND MEMORY (2008)
Noradrenergic, but not cholinergic, deafferentation of prefrontal cortex impairs attentional set-shifting
J. McGaughy et al.
NEUROSCIENCE (2008)
Abnormal expression of glutamate transporter and transporter interacting molecules in prefrontal cortex in elderly patients with schizophrenia
Deborah Bauer et al.
SCHIZOPHRENIA RESEARCH (2008)
α7 nicotinic acetylcholine receptor mRNA expression and binding in postmortem human brain are associated with genetic variation in neuregulin 1
Shiny V. Mathew et al.
HUMAN MOLECULAR GENETICS (2007)
Differential regulation of Fronto-Executive function by the Monoamines and acetylcholine
T. W. Robbins et al.
CEREBRAL CORTEX (2007)
Competitive antagonism between the nicotinic allosteric potentiating ligand galantamine and kynurenic acid at α7*nicotinic receptors
Cristiane Lopes et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
Shifting and stopping: fronto-striatal substrates, neurochemical modulation and clinical implications
T. W. Robbins
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2007)
Elevations of endogenous kynurenic acid produce spatial working memory deficits
Amy C. Chess et al.
SCHIZOPHRENIA BULLETIN (2007)
Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry
Paolo Guidetti et al.
GLIA (2007)
Galantamine improves cognition in schizophrenic patients stabilized on risperidone
Max H. Schubert et al.
BIOLOGICAL PSYCHIATRY (2006)
Proof-of-concept trial of an α7 nicotinic agonist in schizophrenia
Ann Olincy et al.
ARCHIVES OF GENERAL PSYCHIATRY (2006)
Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons
LK Nilsson et al.
JOURNAL OF NEURAL TRANSMISSION (2006)
Using fMRI to decompose the neural processes underlying the Wisconsin Card Sorting Test
CH Lie et al.
NEUROIMAGE (2006)
Selective lesions of the nucleus basalis magnocellularis impair cognitive flexibility
SM Cabrera et al.
BEHAVIORAL NEUROSCIENCE (2006)
Upregulation of the initiating step of the kynurenine pathway in postmortem anterior cingulate cortex from individuals with schizophrenia and bipolar disorder
CL Miller et al.
BRAIN RESEARCH (2006)
Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting
SB Floresco et al.
NEUROPSYCHOPHARMACOLOGY (2006)
Cognitive predictors of psychosocial functioning outcome in schizophrenia: A follow-up study of subjects participating in a rehabilitation program
A Prouteau et al.
SCHIZOPHRENIA RESEARCH (2005)
Nanomolar concentrations of kynurenic acid reduce extracellular dopamine levels in the striatum
A Rassoulpour et al.
JOURNAL OF NEUROCHEMISTRY (2005)
Systemic and prefrontal cortical NMDA receptor blockade differentially affect discrimination learning and set-shift ability in rats
MR Stefani et al.
BEHAVIORAL NEUROSCIENCE (2005)
The primacy of cognition in schizophrenia
RW Heinrichs
AMERICAN PSYCHOLOGIST (2005)
Impairment in perceptual attentional set-shifting following PCP administration: a rodent model of set-shifting deficits in schizophrenia
A Egerton et al.
PSYCHOPHARMACOLOGY (2005)
Expression of the kynurenine pathway enzyme tryptophan 2,3-dioxygenase is increased in the frontal cortex of individuals with schizophrenia
CL Miller et al.
NEUROBIOLOGY OF DISEASE (2004)
Endogenous kynurenic acid disrupts prepulse inhibition
S Erhardt et al.
BIOLOGICAL PSYCHIATRY (2004)
Identification of separable cognitive factors in schizophrenia
KH Nuechterlein et al.
SCHIZOPHRENIA RESEARCH (2004)
Cognitive deficits as treatment targets in schizophrenia
JM Gold
SCHIZOPHRENIA RESEARCH (2004)
Genes, dopamine and cortical signal-to-noise ratio in schizophrenia
G Winterer et al.
TRENDS IN NEUROSCIENCES (2004)
Prefrontal executive and cognitive functions in rodents: neural and neurochemical substrates
JW Dalley et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2004)
Orbital prefrontal cortex mediates reversal learning and not attentional set shifting in the rat
K McAlonan et al.
BEHAVIOURAL BRAIN RESEARCH (2003)
Glutamate receptors in the rat medial prefrontal cortex regulate set-shifting ability
MR Stefani et al.
BEHAVIORAL NEUROSCIENCE (2003)
Micromolar brain levels of kynurenic acid are associated with a disruption of auditory sensory gating in the rat
PD Shepard et al.
NEUROPSYCHOPHARMACOLOGY (2003)
Role of the dorsomedial striatum in behavioral flexibility for response and visual cue discrimination learning
ME Ragozzino et al.
BEHAVIORAL NEUROSCIENCE (2002)
Short-term cognitive improvement in schizophrenics treated with typical and atypical neuroleptics
JD Rollnik et al.
NEUROPSYCHOBIOLOGY (2002)
Kynurenic acid levels are elevated in the cerebrospinal fluid of patients with schizophrenia
S Erhardt et al.
NEUROSCIENCE LETTERS (2001)
Increased cortical kynurenate content in schizophrenia
R Schwarcz et al.
BIOLOGICAL PSYCHIATRY (2001)
Clozapine enhances neurocognition and clinical symptomatology more than standard neuroleptics
SG Potkin et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2001)
Cholinergic systems and schizophrenia: primary pathology or epiphenomena?
TM Hyde et al.
JOURNAL OF CHEMICAL NEUROANATOMY (2001)
Share Paper
